NeuroDerm, Ltd.
Industry
- Pharmaceuticals
- Drug Delivery
- Transdermal
- Controlled Release
- Drug Delivery
- Medical Devices
- Infusion Therapy Equipment and Supplies
- Biotechnology
Latest on NeuroDerm, Ltd.
In an unusual move, three US Food and Drug Administration complete response letters related to manufacturing issues were announced in the same week, all relating to very different products: a gene the
While many many Japanese firms have shifted much of their commercial and R&D focus to the US, several have recently faced development setbacks that could affect their mid-term outlook in this huge mar
The month of June could be among the busiest for US FDA approvals in 2024 to date, thanks to a stacked user fee goal date calendar that features nine novel agents and 13 potential new indications, acc
Venture capital investment is limited for biopharma startups in Israel, with only a few specialized funds active in the market and tough competition for money between biopharma, medtech and digital he